Microarray data for ICC were obtained from the Gene Expression Omnibus (GEO) database (https://www.ncbi.nlm.nih.gov/geo/). Two expression profiling datasets, GSE26566(27) and GSE107943(28), were obtained. The GSE26566 dataset contained 104 ICC samples and 6 normal samples. The GSE107943 dataset contained 30 ICC samples and 27 normal samples, as well as clinicopathological information regarding the tumor samples. All expression profiles were downloaded and processed using the R package of GEOquery (29). The transcriptome profiles of 32 ICC samples and 9 normal samples and clinical information of tumor samples were obtained from The Cancer Genome Atlas (TCGA) database (https://cancergenome.nih.gov/) and analyzed using the R package of TCGAbiolinks (30). The GSE26566 and TCGA datasets were analyzed separately as volcano maps using GraphPad Prism 9 (GraphPad Software; Dotmatics). Log2 fold-change (FC)>1 and P<0.05 were defined as the screening thresholds. Common DEGs of the GSE26566 and TCGA datasets were obtained through the TBtools (31). For the definition of high or low expression levels of ITGB5 in the GSE107943 and TCGA datasets, the expression of ITGB5 was divided into two groups according to the survival status of patients with ICC, and separate receiver operating characteristic curves were obtained to determine the ITGB5 cut-off value with area under the curve >0.8 and P<0.05.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.